132 related articles for article (PubMed ID: 20583428)
1. Predictive factors of azathioprine prescription in adult patients with Crohn's disease.
Karoui S; Bibani N; Serghini M; Kallel L; Ben Mustapha N; Boubaker J; Filali A
Hepatogastroenterology; 2010; 57(98):283-7. PubMed ID: 20583428
[TBL] [Abstract][Full Text] [Related]
2. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
[TBL] [Abstract][Full Text] [Related]
3. [Long term evolution of corticodependant and corticoresistant Crohn's disease patients treated by azzathioprine].
Karoui S; Hamrouni A; Bibani N; Serghini M; Boubaker J; Filali A
Tunis Med; 2011 Jul; 89(7):610-5. PubMed ID: 21780035
[TBL] [Abstract][Full Text] [Related]
4. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
[TBL] [Abstract][Full Text] [Related]
5. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.
Treton X; Bouhnik Y; Mary JY; Colombel JF; Duclos B; Soule JC; Lerebours E; Cosnes J; Lemann M;
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):80-5. PubMed ID: 18849016
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of azathioprine in the treatment of chronic active Crohn's disease: prospective one-year follow-up study. German Imurek Study Group.
Ludwig D; Stange EF
Z Gastroenterol; 1999 Nov; 37(11):1085-91. PubMed ID: 10604222
[TBL] [Abstract][Full Text] [Related]
7. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Kim PS; Zlatanic J; Korelitz BI; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
[TBL] [Abstract][Full Text] [Related]
8. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
9. [Azathioprine for prevention of postoperative recurrence in Crohn's disease].
Abdelli MN; Ben Abdallah H; Houissa F; Bouali MR; Khediri MF
Tunis Med; 2007 Jul; 85(7):569-72. PubMed ID: 18064988
[TBL] [Abstract][Full Text] [Related]
10. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
Cosnes J; Bourrier A; Laharie D; Nahon S; Bouhnik Y; Carbonnel F; Allez M; Dupas JL; Reimund JM; Savoye G; Jouet P; Moreau J; Mary JY; Colombel JF;
Gastroenterology; 2013 Oct; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079
[TBL] [Abstract][Full Text] [Related]
11. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
Ramadas AV; Gunesh S; Thomas GA; Williams GT; Hawthorne AB
Gut; 2010 Sep; 59(9):1200-6. PubMed ID: 20650924
[TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
[TBL] [Abstract][Full Text] [Related]
13. [Diffuse jejuno-ileitis of Crohn's disease: a separate form of the disease?].
Touze I; Gower-Rousseau C; Grandbastien B; Paris JC; Quandalle P; Cortot A; Colombel JF
Gastroenterol Clin Biol; 1999 Mar; 23(3):307-11. PubMed ID: 10384331
[TBL] [Abstract][Full Text] [Related]
14. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
[TBL] [Abstract][Full Text] [Related]
15. Natural history of pediatric Crohn's disease: a population-based cohort study.
Vernier-Massouille G; Balde M; Salleron J; Turck D; Dupas JL; Mouterde O; Merle V; Salomez JL; Branche J; Marti R; Lerebours E; Cortot A; Gower-Rousseau C; Colombel JF
Gastroenterology; 2008 Oct; 135(4):1106-13. PubMed ID: 18692056
[TBL] [Abstract][Full Text] [Related]
16. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
Chebli JM; Gaburri PD; De Souza AF; Pinto AL; Chebli LA; Felga GE; Forn CG; Pimentel CF
J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
[TBL] [Abstract][Full Text] [Related]
18. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
Kull E; Beau P
Gastroenterol Clin Biol; 2002 Apr; 26(4):367-71. PubMed ID: 12070412
[TBL] [Abstract][Full Text] [Related]
19. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
Papi C; Festa V; Leandro G; Moretti A; Tanga M; Koch M; Capurso L
Am J Gastroenterol; 2007 Apr; 102(4):814-9. PubMed ID: 17222316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
